R Wolff1, V Seifert, A Mack, J Steinbach, C Rödel, R Heyd. 1. Zentrum für Radiochirurgie und Präzisionsbestrahlung, Klinikum der J.W. Goethe Universität Frankfurt am Main, Schleusenweg 2-16, 60528, Frankfurt am Main, Germany. robert.wolff@radio-chirurgie.de
Abstract
BACKGROUND AND PURPOSE: The goal of this work was to demonstrate the efficacy of stereotactic gamma knife radiosurgery (GKRS) for the treatment of neurocytoma by means of a case report and a comprehensive literature review. CASE REPORT: A locally recurrent atypical neurocytoma in the area of the left third ventricle thalamic wall occurring 7 years after primary microsurgical resection in a 59-year old woman was treated by GKRS. A marginal dose of 17 Gy was delivered to the surrounding 50% isodose. At the last follow-up, 82 months after radiosurgery, the tumor was locally controlled. For the literature review, computerized bibliographic searches of Pubmed were supplemented with hand searches of reference lists and abstracts of ASCO/ASTRO/ESTRO meetings. DISCUSSION: The present case confirms the results of the literature analysis. From 1997-2011, a total of 14 series were published providing results of GKRS in 86 patients (89 lesions). The marginal doses, which have been applied, ranged from 9.6-20.0 Gy. With median follow-up intervals between 6 and 185 months, local control was 97.2% and local tumor progression of neurocytoma after GKRS was restricted to only 4 cases. In accordance with our own experience, GKRS was not associated with a relevant early or late toxicity. CONCLUSION: GKRS can be assumed to be a safe and effective treatment modality of recurrent or residual neurocytoma.
BACKGROUND AND PURPOSE: The goal of this work was to demonstrate the efficacy of stereotactic gamma knife radiosurgery (GKRS) for the treatment of neurocytoma by means of a case report and a comprehensive literature review. CASE REPORT: A locally recurrent atypical neurocytoma in the area of the left third ventricle thalamic wall occurring 7 years after primary microsurgical resection in a 59-year old woman was treated by GKRS. A marginal dose of 17 Gy was delivered to the surrounding 50% isodose. At the last follow-up, 82 months after radiosurgery, the tumor was locally controlled. For the literature review, computerized bibliographic searches of Pubmed were supplemented with hand searches of reference lists and abstracts of ASCO/ASTRO/ESTRO meetings. DISCUSSION: The present case confirms the results of the literature analysis. From 1997-2011, a total of 14 series were published providing results of GKRS in 86 patients (89 lesions). The marginal doses, which have been applied, ranged from 9.6-20.0 Gy. With median follow-up intervals between 6 and 185 months, local control was 97.2% and local tumor progression of neurocytoma after GKRS was restricted to only 4 cases. In accordance with our own experience, GKRS was not associated with a relevant early or late toxicity. CONCLUSION: GKRS can be assumed to be a safe and effective treatment modality of recurrent or residual neurocytoma.
Authors: Alexander Bertalanffy; Karl Roessler; Oskar Koperek; Ellen Gelpi; Daniela Prayer; Engelbert Knosp Journal: Cancer Date: 2005-07-01 Impact factor: 6.860
Authors: A Bertalanffy; K Roessler; W Dietrich; M Aichholzer; D Prayer; A Ertl; K Kitz Journal: J Neurol Neurosurg Psychiatry Date: 2001-04 Impact factor: 10.154
Authors: James L Leenstra; Fausto J Rodriguez; Christina M Frechette; Caterina Giannini; Scott L Stafford; Bruce E Pollock; Steven E Schild; Bernd W Scheithauer; Robert B Jenkins; Jan C Buckner; Paul D Brown Journal: Int J Radiat Oncol Biol Phys Date: 2006-12-21 Impact factor: 7.038
Authors: Johanna Meisner; Andreas Meyer; Bernd Polivka; Johann H Karstens; Michael Bremer Journal: Strahlenther Onkol Date: 2010-01-26 Impact factor: 3.621
Authors: Marta Navas; Rafael G Sola; Cristina V Torres; Sophia F Shakur; Rafael Manzanares; Carlos Gordillo; Jose A Jimenez Journal: Childs Nerv Syst Date: 2014-05 Impact factor: 1.475